TSBX: Turnstone Biologics Corp. Stock

by  •  • Comments Off on TSBX: Turnstone Biologics Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 70.08
Enterprise Value ($M) 55.65
Book Value ($M) 80.01
Book Value / Share 3.46
Price / Book 0.88
NCAV ($M) 70.60
NCAV / Share 3.05
Price / NCAV 0.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.91
Return on Assets (ROA) -0.81
Return on Equity (ROE) -1.04

Liquidity (mrq)
Quick Ratio 6.72
Current Ratio 6.72

Balance Sheet (mrq) ($M)
Current Assets 84.98
Assets 94.39
Liabilities 14.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 19.31
Operating Income -59.03
Net Income -55.20

Cash Flow Statement (mra) ($M)
Cash From Operations -66.15
Cash from Investing -28.09
Cash from Financing 77.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-29 13G/A Fmr Llc 5.99 -45.56
03-18 13G Langer Timothy 5.60
08-03 13D Versant Venture Capital V, L.P. 12.50
07-27 13G Point72 Asset Management, L.P. 6.20
07-24 13D Orbimed Advisors Llc 13.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-09-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-14 21,694 86,334 25.13
2024-05-13 19,697 27,676 71.17
2024-05-10 37,383 32,230 115.99
2024-05-09 28,345 36,600 77.45

(click for more detail)

Similar Companies
TNGX – Tango Therapeutics, Inc. TRDA – Entrada Therapeutics, Inc.
TRVI – Trevi Therapeutics, Inc. TVTX – Travere Therapeutics, Inc.
URGN – UroGen Pharma Ltd.


Financial data and stock pages provided by
Fintel.io